Has Deborah Hilton, MD received payments from drug or device companies?

Yes. Drug and device makers reported $727 in general payments to Deborah Hilton, MD across 29 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Deborah Hilton, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Deborah Hilton, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Deborah Hilton, MD

Dermatology · Slidell, LANPI 1447462536

Payments from drug & device makers

$727in general payments, 2019–2025

Across 29 payments — averaging $25.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Sanofi$144
UCB, Inc.$142
AbbVie$106
Amgen$68
E.r. Squibb & Sons, L.L.C.$41
Galderma Laboratories, L.p.$32
plus $193 from 11 others

What the payments were for

Food & beverage$727100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Sanofi	2	$144
UCB, Inc.	2	$142
AbbVie(2 entities)	6	$106
Amgen	4	$68
E.r. Squibb & Sons, L.L.C.	2	$41
Galderma Laboratories, L.p.	2	$32
Dermavant Sciences, Inc.	1	$26
Dermira, Inc.	1	$26
Medimetriks Pharmaceuticals, Inc.	1	$23
Incyte Corporation	1	$22
Helsinn Therapeutics (U.S.), Inc.	1	$22
Lilly USA, LLC	1	$17
Organon	1	$15
Ortho Dermatologics, A Division Of Bausch Health US, LLC	1	$13
Mayne Pharma Commercial LLC	1	$13
Pfizer	1	$11
EPI Health, LLC	1	$6

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Bimzelx$125
DUPIXENT$122

How this compares

$727 in reported general payments places this provider in the 15th percentile of 189 dermatology providers in Louisiana.

See all dermatology providers in Louisiana →

Medicare billing

Part B allowed, 2024

$84,250

Medicare patients

274

Services billed

1,278

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Acitretin	14	$2,763
Ketoconazole	49	$999
Doxycycline Hyclate	23	$315
Clobetasol Propionate	15	$242
Mupirocin	16	$197
Triamcinolone Acetonide	14	$180

Paid to pharmacies, not to this prescriber.